Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial

INTRODUCTION: Intracerebral haemorrhage (ICH) can be devastating and is a common cause of death and disability worldwide. Pre-ICH antiplatelet drug use is associated with a 27% relative increase in 1 month case fatality compared with patients not using antithrombotic drugs. We aim to assess the feas...

Descripción completa

Detalles Bibliográficos
Autores principales: Desborough, Michael J R, Al-Shahi Salman, Rustam, Stanworth, Simon J, Havard, Diane, Brennan, Paul M, Dineen, Robert A, Coats, Timothy J, Hepburn, Trish, Bath, Philip M, Sprigg, Nikola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656949/
https://www.ncbi.nlm.nih.gov/pubmed/33172941
http://dx.doi.org/10.1136/bmjopen-2020-037555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656949/
https://www.ncbi.nlm.nih.gov/pubmed/33172941
http://dx.doi.org/10.1136/bmjopen-2020-037555

Ejemplares similares